HOME >> MEDICINE >> NEWS
Bypass surgery tops angioplasty for sickest heart patients

DURHAM, N.C. -- Patients with severe coronary artery disease live longer if they receive coronary artery bypass surgery as their initial treatment instead of artery-opening angioplasty or heart medications, according to a Duke University Medical Center analysis.

Yet up to 40 percent of patients diagnosed with severe coronary disease are treated first with angioplasty or medications and not given the opportunity to receive bypass surgery, the researchers estimate. Bypass surgery is more expensive and more invasive, but has the benefit of increasing patient life span significantly more than the other options, the scientists said.

Bypass surgery involves opening the chest and surgically bypassing blockages in coronary arteries with healthy arteries taken from other parts of the body, most often the legs. Angioplasty involves snaking an expandable balloon through a tube inserted through a blocked coronary artery and then expanding the balloon to push the blockage against the walls of the artery, thereby opening it.

"It may sound very appealing to patients with severe coronary artery disease to get a treatment that is less expensive or less invasive, but they may not be getting the same survival benefit as those patients receiving bypass surgery," said Peter Smith, M.D., chief of cardiothoracic surgery and lead investigator for the study.

"The 40-year history of bypass surgery has shown it to be a durable and reliable treatment for coronary artery disease," Smith said. "It may seem counterintuitive to start a patient on the most invasive treatment option, but our analysis showed that surgery provided significant improvement in longevity for patients with severe disease."

The findings appear in the October 2006 issue of the journal Annals of Thoracic Surgery. The study was supported by the Duke Clinical Research Institute and Duke's Division of Cardiothoracic Surgery.

The researchers retrospectively analyzed the out
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
2-Oct-2006


Page: 1 2 3

Related medicine news :

1. Bypassing eggs, flu vaccine grown in insect cells shows promise
2. HealthGrades study: Bariatric surgery patients have fewer complications at high-volume hospitals
3. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
4. After epilepsy surgery, quality of life related more to seizures than memory
5. Pancreatic surgery riskier for obese patients
6. Second SPORT study shows surgery advantage for spinal stenosis and slipped vertebra
7. Study questions risks of anti-bleeding drug during heart surgery
8. Same-day coronary angiography and surgery safe for many patients
9. Sling surgery is more effective than Burch for bladder control in women
10. Experts debate role of stenting, bypass surgery in left main coronary artery disease
11. Chemotherapy more effective when given before breast cancer surgery

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... 2017 , ... On Sunday, September 24, hundreds will gather at Flo Jo ... considered the fastest woman of all time. Flo Jo passed away from complications ... the National Anthem. Mary was a contestant on the 2012 season of America’s ...
(Date:9/22/2017)... ... September 22, 2017 , ... Ecocor ... Richard Pedranti Architect (RPA), a full-service architecture firm focusing on sustainable ... Solsken Line of Model Homes . Independently, Ecocor and RPA have extensive experience ...
(Date:9/22/2017)... ... September 22, 2017 , ... SABRE is pleased to ... Molli C., a graduate student from Sonora, California, who will begin her studies ... Thomas University in Miami, Florida, was selected from a pool of more than ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Cursed ... of an obligatory tithe, and the freedom experienced when breaking free from this ... published author, Lysa M. Harrison. , Published by Christian Faith Publishing, Lysa M. ...
(Date:9/22/2017)... ... 2017 , ... "Success Files," a short- and long-form documentary ... a disease estimated to affect the lives of more than 5 million Americans ... a leading voice in the fight for cure and research into the disease, ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the ... has been granted Fast Track status by the US Food ... HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company will ... sequential therapy targeting patients who are admitted to Emergency Departments ... ...
(Date:9/5/2017)... -- Xyntek Inc. has announced another milestone in their continued growth and success of ... growing demands of customer engagements regionally.  ... Midwest office is located at 318 West Adams Street, Suite 1528, Chicago, IL ... Xyntek's recently opened Midwest ... In ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology:
Cached News: